INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-185298052-ddPCR]( "ddPCR Workflows For Gene Expression Analysis")
ddPCR Workflows For Gene Expression AnalysisRT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.
-
![global SARS COVID pandemic vaccine-GettyImages-1299440500]( "Keeping The Momentum In Pandemic Preparedness")
Keeping The Momentum In Pandemic PreparednessLearn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.
-
![GettyImages-1227180008 facility design, lab]( "Assessing Developability And Designing Advanceable Formulations From The Start")
Assessing Developability And Designing Advanceable Formulations From The StartDiscover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.
-
![450_300-screenshot_2025_08_06_103131]( "Process Intensification: Your Guide To \"Doing More With Less\"")
Process Intensification: Your Guide To "Doing More With Less"Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions1/13/2026
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates12/11/2024
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Evolving Gene Editing For Rare Disease Drug Development10/9/2025
Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
-
Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations3/20/2026
Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.
DRUG DEVELOPMENT SOLUTIONS
-
![Scientists In Lab Wearing Protective Clothes GettyImages-1087219342]( "ADC And Bioconjugation Center Of Excellence")
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.
-
![Nanoform]( "Controlled Expansion Of Supercritical Solutions (CESS®) Technology")
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
![GettyImages-950086574-microscope-scientist-pill-development]( "Developing Pediatric Formulations")
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
-
![GettyImages-1293772880-Lab-Science-Research-Scientist-Discovery-Development]( "Empowering Biologics Development With HRMS Services")
Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.
-
![GettyImages-1218520471-development-research-lab-PPE]( "Early Development: Accelerating Molecules Through To Proof-Of-Concept")
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
